Key facts
- This page summarizes Richard Ferrari's Form 4 filing for Tenon Medical, Inc. (TNON).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Jan 2026, 20:51.
Richard Ferrari - 01 Jan 2026 Form 4 Insider Report for Tenon Medical, Inc. (TNON)
- Reporting relationship
- Director
- Issuer ticker
- TNON
- Reported as of
- 01 Jan 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Jan 2026, 20:51:12 UTC
- Prior SEC filing
- 15 Oct 2025
- Next SEC filing
- 23 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Richard Ferrari
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Richard Ferrari filed Form 4 for Tenon Medical, Inc. (TNON) on 05 Jan 2026.
Change
- Previous filing in this sequence was filed on 15 Oct 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001034413
Primary reporting owner
Ferrari Richard
- Relationship
- Director
- Address
- 104 COOPER COURT, LOS GATOS
- Signature
- /s/ Richard Ferrari
- Signature date
- 05 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TNON
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +64,478
- Change %
- +1026%
- Price
- $0.000000
- Shares after
- 70,764
- Date
- 01 Jan 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TNON
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -64,479
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 64,479
- Date
- 01 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 64,479
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents conversion of 64,479 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 64,479 shares of common stock of the Issuer on January 1, 2026.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.